Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern

In the absence of virus-targeting small-molecule drugs approved for the treatment and prevention of COVID-19, broadening the repertoire of potent SARS-CoV-2-neutralizing antibodies represents an important area of research in response to the ongoing pandemic. Systematic analysis of such antibodies an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorchakov, Andrey A., Kulemzin, Sergey V., Guselnikov, Sergey V., Baranov, Konstantin O., Belovezhets, Tatyana N., Mechetina, Ludmila V., Volkova, Olga Yu., Najakshin, Alexander M., Chikaev, Nikolai A., Chikaev, Anton N., Solodkov, Pavel P., Larichev, Victor F., Gulyaeva, Marina A., Markhaev, Alexander G., Kononova, Yulia V., Alekseyev, Alexander Yu., Shestopalov, Alexander M., Yusubalieva, Gaukhar M., Klypa, Tatiana V., Ivanov, Alexander V., Valuev-Elliston, Vladimir T., Baklaushev, Vladimir P., Taranin, Alexander V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526700/
https://www.ncbi.nlm.nih.gov/pubmed/34667147
http://dx.doi.org/10.1038/s41421-021-00340-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526700/
https://www.ncbi.nlm.nih.gov/pubmed/34667147
http://dx.doi.org/10.1038/s41421-021-00340-8

Ejemplares similares